Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

NleB/SseK effectors from Citrobacter rodentium, Escherichia coli, and Salmonella enterica display distinct differences in host substrate specificity.

El Qaidi S, Chen K, Halim A, Siukstaite L, Rueter C, Hurtado-Guerrero R, Clausen H, Hardwidge PR.

J Biol Chem. 2017 Jul 7;292(27):11423-11430. doi: 10.1074/jbc.M117.790675. Epub 2017 May 18.

2.

The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD).

Scott NE, Giogha C, Pollock GL, Kennedy CL, Webb AI, Williamson NA, Pearson JS, Hartland EL.

J Biol Chem. 2017 Oct 20;292(42):17337-17350. doi: 10.1074/jbc.M117.805036. Epub 2017 Aug 31.

3.

Mutagenesis and Functional Analysis of the Bacterial Arginine Glycosyltransferase Effector NleB1 from Enteropathogenic Escherichia coli.

Wong Fok Lung T, Giogha C, Creuzburg K, Ong SY, Pollock GL, Zhang Y, Fung KY, Pearson JS, Hartland EL.

Infect Immun. 2016 Apr 22;84(5):1346-1360. doi: 10.1128/IAI.01523-15. Print 2016 May.

4.

A type III effector antagonizes death receptor signalling during bacterial gut infection.

Pearson JS, Giogha C, Ong SY, Kennedy CL, Kelly M, Robinson KS, Lung TW, Mansell A, Riedmaier P, Oates CV, Zaid A, Mühlen S, Crepin VF, Marches O, Ang CS, Williamson NA, O'Reilly LA, Bankovacki A, Nachbur U, Infusini G, Webb AI, Silke J, Strasser A, Frankel G, Hartland EL.

Nature. 2013 Sep 12;501(7466):247-51. doi: 10.1038/nature12524.

5.

NleB, a bacterial effector with glycosyltransferase activity, targets GAPDH function to inhibit NF-κB activation.

Gao X, Wang X, Pham TH, Feuerbacher LA, Lubos ML, Huang M, Olsen R, Mushegian A, Slawson C, Hardwidge PR.

Cell Host Microbe. 2013 Jan 16;13(1):87-99. doi: 10.1016/j.chom.2012.11.010. Epub 2013 Jan 16. Erratum in: Cell Host Microbe. 2013 Mar 13;13(3):371-2.

6.

SseK1 and SseK3 Type III Secretion System Effectors Inhibit NF-κB Signaling and Necroptotic Cell Death in Salmonella-Infected Macrophages.

Günster RA, Matthews SA, Holden DW, Thurston TLM.

Infect Immun. 2017 Feb 23;85(3). pii: e00010-17. doi: 10.1128/IAI.00010-17. Print 2017 Mar. Erratum in: Infect Immun. 2017 May 23;85(6):.

7.

Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains.

Li S, Zhang L, Yao Q, Li L, Dong N, Rong J, Gao W, Ding X, Sun L, Chen X, Chen S, Shao F.

Nature. 2013 Sep 12;501(7466):242-6. doi: 10.1038/nature12436. Epub 2013 Aug 18.

PMID:
23955153
8.

Citrobacter rodentium NleB Protein Inhibits Tumor Necrosis Factor (TNF) Receptor-associated Factor 3 (TRAF3) Ubiquitination to Reduce Host Type I Interferon Production.

Gao X, Pham TH, Feuerbacher LA, Chen K, Hays MP, Singh G, Rueter C, Hurtado-Guerrero R, Hardwidge PR.

J Biol Chem. 2016 Aug 26;291(35):18232-8. doi: 10.1074/jbc.M116.738278. Epub 2016 Jul 7.

9.

Distinct Roles of the Antiapoptotic Effectors NleB and NleF from Enteropathogenic Escherichia coli.

Pollock GL, Oates CVL, Giogha C, Wong Fok Lung T, Ong SY, Pearson JS, Hartland EL.

Infect Immun. 2017 Mar 23;85(4). pii: e01071-16. doi: 10.1128/IAI.01071-16. Print 2017 Apr.

10.

High-Throughput Screening for Bacterial Glycosyltransferase Inhibitors.

El Qaidi S, Zhu C, McDonald P, Roy A, Maity PK, Rane D, Perera C, Hardwidge PR.

Front Cell Infect Microbiol. 2018 Dec 18;8:435. doi: 10.3389/fcimb.2018.00435. eCollection 2018.

11.

EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation.

Berger CN, Crepin VF, Baruch K, Mousnier A, Rosenshine I, Frankel G.

MBio. 2012 Oct 2;3(5). pii: e00317-12. doi: 10.1128/mBio.00317-12. Print 2012.

12.

Type Three Secretion System in Attaching and Effacing Pathogens.

Gaytán MO, Martínez-Santos VI, Soto E, González-Pedrajo B.

Front Cell Infect Microbiol. 2016 Oct 21;6:129. eCollection 2016. Review.

13.

Enteropathogenic and enterohemorrhagic Escherichia coli type III secretion effector EspV induces radical morphological changes in eukaryotic cells.

Arbeloa A, Oates CV, Marchès O, Hartland EL, Frankel G.

Infect Immun. 2011 Mar;79(3):1067-76. doi: 10.1128/IAI.01003-10. Epub 2010 Dec 28.

14.

The inhibition of COPII trafficking is important for intestinal epithelial tight junction disruption during enteropathogenic Escherichia coli and Citrobacter rodentium infection.

Thanabalasuriar A, Kim J, Gruenheid S.

Microbes Infect. 2013 Sep-Oct;15(10-11):738-44. doi: 10.1016/j.micinf.2013.05.001. Epub 2013 Jun 6.

PMID:
23747681
15.

Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation.

Sham HP, Shames SR, Croxen MA, Ma C, Chan JM, Khan MA, Wickham ME, Deng W, Finlay BB, Vallance BA.

Infect Immun. 2011 Sep;79(9):3552-62. doi: 10.1128/IAI.05033-11. Epub 2011 Jul 11.

16.

Structural basis for arginine glycosylation of host substrates by bacterial effector proteins.

Park JB, Kim YH, Yoo Y, Kim J, Jun SH, Cho JW, El Qaidi S, Walpole S, Monaco S, García-García AA, Wu M, Hays MP, Hurtado-Guerrero R, Angulo J, Hardwidge PR, Shin JS, Cho HS.

Nat Commun. 2018 Oct 16;9(1):4283. doi: 10.1038/s41467-018-06680-6.

17.

Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.

Wong AR, Pearson JS, Bright MD, Munera D, Robinson KS, Lee SF, Frankel G, Hartland EL.

Mol Microbiol. 2011 Jun;80(6):1420-38. doi: 10.1111/j.1365-2958.2011.07661.x. Epub 2011 May 5. Review.

18.

Modelling of infection by enteropathogenic Escherichia coli strains in lineages 2 and 4 ex vivo and in vivo by using Citrobacter rodentium expressing TccP.

Girard F, Crepin VF, Frankel G.

Infect Immun. 2009 Apr;77(4):1304-14. doi: 10.1128/IAI.01351-08. Epub 2009 Feb 2.

19.

Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium.

Kelly M, Hart E, Mundy R, Marchès O, Wiles S, Badea L, Luck S, Tauschek M, Frankel G, Robins-Browne RM, Hartland EL.

Infect Immun. 2006 Apr;74(4):2328-37.

20.

Bacterial Adrenergic Sensors Regulate Virulence of Enteric Pathogens in the Gut.

Moreira CG, Russell R, Mishra AA, Narayanan S, Ritchie JM, Waldor MK, Curtis MM, Winter SE, Weinshenker D, Sperandio V.

MBio. 2016 Jun 7;7(3). pii: e00826-16. doi: 10.1128/mBio.00826-16.

Supplemental Content

Support Center